Medicare Advantage or Medigap When You Have Diabetes? Run the Numbers Like a Chronic Condition

The mailbox fills up the year you turn 65: glossy Advantage cards promising $0 premiums, dental, a gym membership. And you are reading them differently than your neighbor does, because you have a Dexcom on your arm, an endocrinologist you waited four months to get, and a pharmacy routine that actually works. The generic comparison charts do not mention any of that. This guide runs the same Advantage-or-Medigap decision everyone faces, through the lens of the condition you will be managing every single month of it.

Why diabetes changes the math

Insurance trade-offs hinge on how much care you will use, and diabetes removes the mystery. You already know next year holds visits every 3 to 6 months (possibly with an endocrinologist), monthly CGM or pump supplies, a dilated eye exam, kidney labs, foot checks, and a steady drug list. Advantage plans charge as you go: a copay per specialist visit, cost sharing on supplies Medicare covers, and prior authorization gates on the expensive items. That structure is kindest to people who barely use care and heaviest on people with a standing monthly appointment with the healthcare system, which is you. Medigap inverts it: a real premium every month (commonly $100 to $300 by age, plan, and state), in exchange for near-zero variability on Part A and B services. For a chronic condition, you are choosing between a predictable premium and an unpredictable pile of copays, and the pile grows with every service you already know you need. A strong Advantage plan can still work for diabetes; the word doing the work is "strong," and you can only tell by checking the plan against your actual care, line by line, before you enroll.

The checkpoints before choosing Advantage with diabetes

• Is your endocrinologist in network? Your whole health system? Check the plan's directory for every doctor you see, and confirm by calling the office, since directories run stale. Losing a hard-won endo to a network is an expensive way to save on premiums; if yours is scarce, remember how long the wait was.
• How does the plan cover CGM supplies, and through which channel? DME versus pharmacy changes your suppliers, your refill friction, and your cost per month; the pharmacy vs DME guide explains the difference. Ask the plan which channel your sensors run through and what you pay there.
• What is the prior authorization burden on pumps and CGMs? Advantage plans use prior auth heavily, and device-dependent diabetes care feels it most: new pump, sensor upgrades, resupply reauthorizations. Ask the plan what device categories require it and how often it renews.
• Run the drug formulary against your exact list. Your specific insulin, your GLP-1 if you take one, tiers and quantity limits included. Drug coverage in Advantage plans follows the same Part D rules, including the annual out-of-pocket cap and its monthly payment plan.
• Read the maximum out-of-pocket as a realist. The in-network cap can run as high as $9,250 for 2026. A healthy enrollee treats that as a never-hit ceiling; a chronic user should treat it as a plausible bad-year number and ask whether the premium savings still look good next to it.

What Medigap plus Part D buys instead

With Medigap riding alongside Original Medicare, there is no network: any doctor in the country that takes Medicare, which includes almost every endocrinologist, retina specialist, and podiatrist you might ever be referred to. Prior authorization essentially disappears from your Part A and B care, CGM supplies flow through Medicare's standard DME coverage with Medigap absorbing the 20% coinsurance, and your out-of-pocket for covered services rounds toward zero. You add a standalone Part D plan for drugs, chosen against your formulary the same careful way.

The catch deserves bold: the clean entrance has a deadline. Your Medigap open enrollment period is the 6 months starting when you are 65+ and enrolled in Part B, and during it insurers must sell to you regardless of health. After it closes, in most states, switching into Medigap means medical underwriting: an application that asks about your health, where diabetes (especially insulin-treated) can mean a higher premium or an outright denial. A handful of states guarantee access anyway; most do not. So the plan of "try Advantage, switch to Medigap if diabetes gets harder" often fails at exactly the moment you would want it, because the switch requires passing underwriting with the condition that made you want to switch. If you start in Advantage at 65, note the 12-month federal trial right to return, and mark the date.

The insulin cap, and the extras, weighed honestly

Two things sit outside the rivalry. First, the $35 monthly insulin cap applies in both worlds: Medicare's insulin rules cap a month's supply of covered insulin at $35 whether your drug coverage comes from a standalone Part D plan or an Advantage plan, details in the insulin cap guide. Insulin cost alone should never decide this choice. Second, the Advantage extras (dental, vision, hearing, the OTC card) are real money, often a few hundred dollars a year of value. Weigh them at that size: next to the visit copays, device cost sharing, and prior auth friction of a chronic condition, they are a rounding term. Choosing a plan for the dental benefit while your endo is out of network is the classic mistake.

How to decide, honestly

There is no best plan for diabetics, only a best fit for your management style and budget. High-touch diabetes (insulin, a pump or CGM, an endo you rely on, complications being watched) leans Medigap if the premium is affordable at 65, because you are exactly the user Advantage's cost sharing and gatekeeping land on hardest, and exactly the applicant underwriting later screens out. Budget-constrained, and healthy apart from well-controlled diabetes, with your full care team confirmed in network and your drugs on formulary, can genuinely do fine in a strong Advantage plan, especially where Medigap premiums run high. Whichever you pick, reread the plan's Annual Notice of Change every fall and recheck the fit during open enrollment, October 15 to December 7, because formularies, networks, and prior auth lists shift yearly even when you change nothing.